HALO logo
halo search icon
6472
Bora Pharmaceuticals Co Ltd

6472 · Bora Pharmaceuticals Co Ltd

392.50

TWD
-8.50 (-2.12%)
24/07/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

NT$51.23B

PE

20.40

EV/EBITDA

19.2

DIV Yield

2%

Payout Ratio

42%

MQV Rating

5Very Weak

As at 24/07/2026 12:00:00 AM

Price Chart

Description

Bora Pharmaceuticals Co., Ltd. engages in the manufacturing and sales of generic, brand, and over-the-counter drugs. Its products include central nervous system medication, cardiovascular medicine, antibiotics, antivirals, ophthalmic, antipsychotics, dementia drugs, sleeping agents, lowering blood pressure drugs, and health food. The firm operates through the following segments: Sales, Manufacturing, and Other Segment. The Sales segment comprises of the pharmaceuticals and healthcare products. The Manufacturing segment consists of Contract development & manufacturing organization of pharmaceuticals. The Other Segment refers to the distributing and developing pharmaceuticals. Bora Pharmaceuticals was founded on June 12, 2007 and is headquartered in Taipei, Taiwan.

  • All-Companies
  • All-Consensus
  • HALO 200
  • HALO All
  • HALO Small
  • Short Term Trend - Short

Key Fundamentals

EPS 3 yr Growth

101.00%

EBITDA Margin

22.30%

Operating Cashflow

NT$4,242m

Free Cash Flow Return

15.20%

ROIC

15.70%

Interest Coverage

8.70

Quick Ratio

1.20

Performance

52 weeks range

Low 330.5 - 795

Trade Value (12mth)

US$4,430,568.00

1 week

-3.49%

1 month

-9.58%

YTD

-18.5%

1 year

-42.24%

All time high

812.64

Additional Data

Shares Outstanding (Fully Diluted)

132m

HALO Sector

Healthcare

Next Company Report Date

10-Mar-27

Next Ex Dividend Date

31-Jul-26

Next Dividend Pay Date

26-Aug-26

Reporting Currency

TWD

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Very Weak

Event

Very Strong

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Neutral

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Bora Pharmaceuticals Co Ltd (6472:TAI)?
Halo FAQ
The current share price of Bora Pharmaceuticals Co Ltd (6472:TAI) is TWDNT$392.50.
2
What is the 52-week high share price for Bora Pharmaceuticals Co Ltd (6472:TAI)?
Halo FAQ
The 52-week high share price for Bora Pharmaceuticals Co Ltd (6472:TAI) is TWDNT$795.00.
3
What is the 52-week low share price for Bora Pharmaceuticals Co Ltd (6472:TAI)?
Halo FAQ
The 52-week low share price for Bora Pharmaceuticals Co Ltd (6472:TAI) is TWDNT$330.50.
4
What is the dividend yield for Bora Pharmaceuticals Co Ltd (6472:TAI)?
Halo FAQ
The current TTM dividend payout for Bora Pharmaceuticals Co Ltd (6472:TAI) is 2.00.
5
What was Bora Pharmaceuticals Co Ltd (6472:TAI) last dividend payment?
Halo FAQ
The last dividend payment of Bora Pharmaceuticals Co Ltd (6472:TAI) is TWDNT$14.00.
6
What is the franking level for Bora Pharmaceuticals Co Ltd (6472:TAI)?
Halo FAQ
Bora Pharmaceuticals Co Ltd (6472:TAI) has a franking level of 0.00%.
7
In which sector is Bora Pharmaceuticals Co Ltd (6472:TAI) classified?
Halo FAQ
Bora Pharmaceuticals Co Ltd (6472:TAI) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Bora Pharmaceuticals Co Ltd (6472:TAI)?
Halo FAQ
The current P/E ratio for Bora Pharmaceuticals Co Ltd (6472:TAI) is 20.40.